{"Title": ["3 of the Best Biotech ETFs on the Market", "Healthcare ETFs Sink on JNJ News, ACA Ruling: What???s Ahead?", "Top and Flop ETFs at Half-Way Q4", "ETF Areas That Spooked Investors in October", "ETF of the Week: Virtus LifeSci Biotech Clinical Trials ETF (BBC)", "Scared of a September Lull? Play 6 ETFs", "5 Safe and Sound ETF Strategies for 2H", "5 ETFs to Play in July", "3 of the Best Biotech ETFs on the Market", "How to Build a Winning ETF Portfolio Amid Trade War Fears", "Sarepta Pharma Pushes Two Biotech ETFs to New Highs", "5 Ultra Cheap PEG Stocks Value Investors Will Love", "5 Biotech ETFs for Outsized Gains", "The 8 Best ETFs to Buy to Invest in Biotech Stocks", "Why These Small Cap Biotech ETFs are Soaring", "Best and Worst ETFs of Last Week", "5 ETFs to Play in July", "Biotech Crushing the Market: Best ETFs & Stocks YTD", "Biotech ETF (BBC) Hits New 52-Week High", "M&A Waves Pushing Biotech ETFs Higher", "The Zacks Analyst Blog Highlights: Virtus LifeSci Biotech Clinical, SPDR S&P Biotech, iShares North American Tech-Software, PowerShares Dynamic Semiconductors and Restoration Hardware", "Tax Reform: A Boon or Bane for Small-Cap ETFs?", "Value Biotech ETFs to Buy Now", "ROKU Inc Stock Doesn\u2019t Deserve to Trade for $40+", "4 Sector ETFs to Ride on Strong Beat Ratios", "Biotech Crushing the Market: Best ETFs & Stocks YTD", "Biotech ETF (BBC) Hits New 52-Week High", "M&A Waves Pushing Biotech ETFs Higher", "The Zacks Analyst Blog Highlights: Virtus LifeSci Biotech Clinical, SPDR S&P Biotech, iShares North American Tech-Software, PowerShares Dynamic Semiconductors and Restoration Hardware", "Tax Reform: A Boon or Bane for Small-Cap ETFs?", "Value Biotech ETFs to Buy Now", "ROKU Inc Stock Doesn\u2019t Deserve to Trade for $40+", "4 Sector ETFs to Ride on Strong Beat Ratios", "The Zacks Analyst Blog Highlights: BioShares Biotechnology Clinical Trials, PowerShares Dynamic Semiconductors Fund, PowerShares S&P SmallCap Utilities Portfolio, PowerShares S&P SmallCap Energy Fund and Guggenheim S&P SmallCap 600 Pure V", "Trump Nearing 100 Days in Office: ETF Winners & Losers", "The Zacks Analyst Blog Highlights: BioShares Biotechnology Clinical Trials, Global X MSCI Argentina, iPath S&P 500 VIX Short-Term Futures, iPath Bloomberg Natural Gas Subindex Total Return and iPath Global Carbon", "Best and Worst Zones of Q1 and Their ETFs", "5 Top Performing Stocks of the Best ETF of Q1", "Brexit Weighs On Dow Jones Industrial Average; Nasdaq Notches Fourth Straight Win", "Trumpcare Collapse Fuels Rally in Healthcare Stocks & ETFs", "5 Reasons Why Biotech ETFs are Soaring", "The Zacks Analyst Blog Highlights: BioShares Biotechnology Clinical Trials, PowerShares Dynamic Semiconductors Fund, PowerShares S&P SmallCap Utilities Portfolio, PowerShares S&P SmallCap Energy Fund and Guggenheim S&P SmallCap 600 Pure V", "Trump Nearing 100 Days in Office: ETF Winners & Losers", "The Zacks Analyst Blog Highlights: BioShares Biotechnology Clinical Trials, Global X MSCI Argentina, iPath S&P 500 VIX Short-Term Futures, iPath Bloomberg Natural Gas Subindex Total Return and iPath Global Carbon", "Best and Worst Zones of Q1 and Their ETFs", "5 Top Performing Stocks of the Best ETF of Q1", "Brexit Weighs On Dow Jones Industrial Average; Nasdaq Notches Fourth Straight Win", "Doubt Over Trump Agenda Put These ETFs in Focus", "The Zacks Analyst Blog Highlights: BioShares Biotechnology Clinical Trials Fund, WisdomTree Japan Hedged Quality Dividend Growth Fund, ETF SPDR S&P 500 ETF, iShares Russell 1000 Growth ETF and iShares Russell 1000 Value ETF", "Too Many ETFs Flying in the Market?", "Best Sector ETFs for Q3", "Top and Flop Sector ETFs YTD", "Top and Flop ETFs of 1H", "ForexLive Asia FX news wrap: \u2018Leave\u2019 gets up, GBP smashed to 30 year low", "The Zacks Analyst Blog Highlights: BioShares Biotechnology Clinical Trials Fund, Global X Junior MLP, PowerShares S&P SmallCap Information Technology Portfolio, iShares Morningstar Small-Cap Growth and Guggenheim S&P SmallCap 600 Pure Growth", "Insurance & Cutting Tax Bills", "Zacks Investment Ideas feature highlights: Juno Therapeutics, Genocea Biosciences, Merrimack Pharmaceuticals and BioShares Biotechnology Clinical Trials ETF", "The Zacks Analyst Blog Highlights: PureFunds ISE Junior Silver ETF, SPDR S&P North American Natural Resources ETF, PowerShares DB Gold Fund, BioShares Biotechnology Clinical Trials Fund and iPath Bloomberg Natural Gas Subindex Total Return ETN", "Top and Flop Zones of Q1 and Their ETFs", "3 ETF Sectors Crushed By January Volatility", "The Zacks Analyst Blog Highlights: iShares Nasdaq Biotechnology ETF, SPDR S&P Biotech ETF, ALPS Medical Breakthroughs ETF and BioShares Biotechnology Clinical Trials Fund", "Best and Worst ETFs of January", "Biotech ETFs Hit 52-Week Lows: Time to Buy?", "Market on Rise: 5 Small Cap ETFs Leading The Way", "How to Sell Your Business", "Top & Flop ETFs of November", "4 Sector ETFs Crushing the Market in Q4", "Breakthrough Biotech ETF on Cancer Treatment", "Ill at Ease with Biotech? Prescribing #1 Healthcare ETFs", "How to Grow a Business", "Biotech Boom Over? 3 Health Care ETFs to Invest in Instead", "Small Business Value Improvement", "Is Your Biotech ETF Keeping Up With 3 New Standouts?", "Best and Worst ETF Performers of March - ETF News And Commentary", "Healthcare ETFs Rally on Monday Merger Mania - ETF News And Commentary", "Best And Worst ETFs Of The Week Amid Slowing Corporate Profits", "Sell-Off in Biotech, Semiconductor ETFs: A Nice Entry Point? - ETF News And Commentary", "3 Biotech ETFs in Focus as Biogen Soars - ETF News And Commentary", "New Biotech ETFs Highlight Evolving Growth Opportunities", "Manager Of Hot New Biotech ETFs Explains The Strategy", "SBIO Vs. BBC: 2 Innovative Biotech ETFs Head-To-Head - ETF News And Commentary", "Cut Biz Tax With Life Policies", "ALPS Puts Twist on Biotech Investing with Medical Breakthrough ETF - ETF News And Commentary", "Viral Investing: Ebola Drug Makers' Varied Strategies", "Inside the Two New Innovative Biotech ETFs from BioShares - ETF News And Commentary", "2 New Biotech ETFs Offer Unique Industry Focus", "GoldCore Update: Gold Marginally Lower as Equities Fall Sharply on Disappointing US Job Numbers", "Zacks Investment Ideas feature highlights: Biogen, Amgen, SPDR S&P Biotech ETF, BioShares Biotechnology Clinical Trials Fund and ProShares Ultra Nasdaq Biotechnology ETF - Press Releases"], "Elapsed Time": ["JAN 2, 2020", "DEC 18, 2018", "NOV 20, 2018", "OCT 31, 2018", "SEP 17, 2018", "SEP 4, 2018", "JUL 12, 2018", "JUL 10, 2018", "JAN 2, 2020", "JUN 22, 2018", "JUN 20, 2018", "MAY 15, 2018", "APR 25, 2018", "APR 19, 2018", "APR 18, 2018", "APR 9, 2018", "JUL 9, 2018", "FEB 27, 2018", "JAN 23, 2018", "JAN 18, 2018", "DEC 27, 2017", "DEC 19, 2017", "DEC 13, 2017", "DEC 5, 2017", "MAR 6, 2018", "FEB 27, 2018", "JAN 23, 2018", "JAN 18, 2018", "DEC 27, 2017", "DEC 19, 2017", "DEC 13, 2017", "DEC 5, 2017", "MAR 6, 2018", "APR 28, 2017", "APR 27, 2017", "MAR 31, 2017", "MAR 30, 2017", "MAR 30, 2017", "MAR 29, 2017", "MAR 28, 2017", "JUN 22, 2017", "APR 28, 2017", "APR 27, 2017", "MAR 31, 2017", "MAR 30, 2017", "MAR 30, 2017", "MAR 29, 2017", "MAR 22, 2017", "AUG 10, 2016", "AUG 9, 2016", "JUL 21, 2016", "JUL 5, 2016", "JUN 30, 2016", "JUN 23, 2016", "JUN 7, 2016", "AUG 17, 2016", "APR 11, 2016", "APR 1, 2016", "MAR 31, 2016", "FEB 2, 2016", "FEB 2, 2016", "FEB 1, 2016", "FEB 1, 2016", "JUN 3, 2016", "DEC 2, 2015", "NOV 30, 2015", "NOV 18, 2015", "OCT 19, 2015", "SEP 28, 2015", "SEP 1, 2015", "AUG 13, 2015", "DEC 30, 2015", "JUL 16, 2015", "APR 1, 2015", "MAR 31, 2015", "MAR 28, 2015", "MAR 26, 2015", "MAR 23, 2015", "MAR 17, 2015", "JUL 16, 2015", "MAR 4, 2015", "JAN 23, 2015", "JAN 14, 2015", "DEC 26, 2014", "DEC 23, 2014", "DEC 18, 2014", "JUN 4, 2010", "MAR 16, 2015"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/3-of-the-best-biotech-etfs-on-the-market-2020-01-02", "https://www.nasdaq.com/articles/healthcare-etfs-sink-jnj-news-aca-ruling-whats-ahead-2018-12-18", "https://www.nasdaq.com/articles/top-and-flop-etfs-half-way-q4-2018-11-20", "https://www.nasdaq.com/articles/etf-areas-spooked-investors-october-2018-10-31", "https://www.nasdaq.com/articles/etf-week-virtus-lifesci-biotech-clinical-trials-etf-bbc-2018-09-17", "https://www.nasdaq.com/articles/scared-september-lull-play-6-etfs-2018-09-04", "https://www.nasdaq.com/articles/5-safe-and-sound-etf-strategies-2h-2018-07-12", "https://www.nasdaq.com/articles/5-etfs-play-july-2018-07-10", "https://www.nasdaq.com/articles/3-of-the-best-biotech-etfs-on-the-market-2020-01-02", "https://www.nasdaq.com/articles/how-build-winning-etf-portfolio-amid-trade-war-fears-2018-06-22", "https://www.nasdaq.com/articles/sarepta-pharma-pushes-two-biotech-etfs-new-highs-2018-06-20", "https://www.nasdaq.com/articles/5-ultra-cheap-peg-stocks-value-investors-will-love-2018-05-15", "https://www.nasdaq.com/articles/5-biotech-etfs-outsized-gains-2018-04-25", "https://www.nasdaq.com/articles/8-best-etfs-buy-invest-biotech-stocks-2018-04-19", "https://www.nasdaq.com/articles/why-these-small-cap-biotech-etfs-are-soaring-2018-04-18", "https://www.nasdaq.com/articles/best-and-worst-etfs-last-week-2018-04-09", "https://www.nasdaq.com/articles/5-etfs-play-july-2018-07-09", "https://www.nasdaq.com/articles/biotech-crushing-market-best-etfs-stocks-ytd-2018-02-27", "https://www.nasdaq.com/articles/biotech-etf-bbc-hits-new-52-week-high-2018-01-23", "https://www.nasdaq.com/articles/ma-waves-pushing-biotech-etfs-higher-2018-01-18", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-virtus-lifesci-biotech-clinical-spdr-sp-biotech-ishares", "https://www.nasdaq.com/articles/tax-reform-boon-or-bane-small-cap-etfs-2017-12-19", "https://www.nasdaq.com/articles/value-biotech-etfs-buy-now-2017-12-13", "https://www.nasdaq.com/articles/roku-inc-stock-doesnt-deserve-to-trade-for-%2440-2017-12-05", "https://www.nasdaq.com/articles/4-sector-etfs-ride-strong-beat-ratios-2018-03-06", "https://www.nasdaq.com/articles/biotech-crushing-market-best-etfs-stocks-ytd-2018-02-27", "https://www.nasdaq.com/articles/biotech-etf-bbc-hits-new-52-week-high-2018-01-23", "https://www.nasdaq.com/articles/ma-waves-pushing-biotech-etfs-higher-2018-01-18", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-virtus-lifesci-biotech-clinical-spdr-sp-biotech-ishares", "https://www.nasdaq.com/articles/tax-reform-boon-or-bane-small-cap-etfs-2017-12-19", "https://www.nasdaq.com/articles/value-biotech-etfs-buy-now-2017-12-13", "https://www.nasdaq.com/articles/roku-inc-stock-doesnt-deserve-to-trade-for-%2440-2017-12-05", "https://www.nasdaq.com/articles/4-sector-etfs-ride-strong-beat-ratios-2018-03-06", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-bioshares-biotechnology-clinical-trials-powershares", "https://www.nasdaq.com/articles/trump-nearing-100-days-office-etf-winners-losers-2017-04-27", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-bioshares-biotechnology-clinical-trials-global-x-msci", "https://www.nasdaq.com/articles/best-and-worst-zones-q1-and-their-etfs-2017-03-30", "https://www.nasdaq.com/articles/5-top-performing-stocks-best-etf-q1-2017-03-30", "https://www.nasdaq.com/articles/brexit-weighs-dow-jones-industrial-average-nasdaq-notches-fourth-straight-win-2017-03-29", "https://www.nasdaq.com/articles/trumpcare-collapse-fuels-rally-healthcare-stocks-etfs-2017-03-28", "https://www.nasdaq.com/articles/5-reasons-why-biotech-etfs-are-soaring-2017-06-22", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-bioshares-biotechnology-clinical-trials-powershares", "https://www.nasdaq.com/articles/trump-nearing-100-days-office-etf-winners-losers-2017-04-27", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-bioshares-biotechnology-clinical-trials-global-x-msci", "https://www.nasdaq.com/articles/best-and-worst-zones-q1-and-their-etfs-2017-03-30", "https://www.nasdaq.com/articles/5-top-performing-stocks-best-etf-q1-2017-03-30", "https://www.nasdaq.com/articles/brexit-weighs-dow-jones-industrial-average-nasdaq-notches-fourth-straight-win-2017-03-29", "https://www.nasdaq.com/articles/doubt-over-trump-agenda-put-these-etfs-focus-2017-03-22", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-bioshares-biotechnology-clinical-trials-fund-wisdomtree", "https://www.nasdaq.com/articles/too-many-etfs-flying-in-the-market-2016-08-09", "https://www.nasdaq.com/articles/best-sector-etfs-for-q3-2016-07-21", "https://www.nasdaq.com/articles/top-and-flop-sector-etfs-ytd-2016-07-05", "https://www.nasdaq.com/articles/top-and-flop-etfs-of-1h-2016-06-30", "https://www.nasdaq.com/articles/forexlive-asia-fx-news-wrap-leave-gets-gbp-smashed-30-year-low-2016-06-23", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-bioshares-biotechnology-clinical-trials-fund-global-x", "https://www.nasdaq.com/articles/insurance-cutting-tax-bills-2016-08-17", "https://www.nasdaq.com/articles/zacks-investment-ideas-feature-highlights%3A-juno-therapeutics-genocea-biosciences-merrimack", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-purefunds-ise-junior-silver-etf-spdr-sp-north-american", "https://www.nasdaq.com/articles/top-and-flop-zones-q1-and-their-etfs-2016-03-31", "https://www.nasdaq.com/articles/3-etf-sectors-crushed-january-volatility-2016-02-02", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-ishares-nasdaq-biotechnology-etf-spdr-sp-biotech-etf", "https://www.nasdaq.com/articles/best-and-worst-etfs-of-january-2016-02-01", "https://www.nasdaq.com/articles/biotech-etfs-hit-52-week-lows-time-buy-2016-02-01", "https://www.nasdaq.com/articles/market-rise-5-small-cap-etfs-leading-way-2016-06-03", "https://www.nasdaq.com/articles/how-sell-your-business-2015-12-02", "https://www.nasdaq.com/articles/top-flop-etfs-of-november-2015-11-30", "https://www.nasdaq.com/articles/4-sector-etfs-crushing-market-q4-2015-11-18", "https://www.nasdaq.com/articles/breakthrough-biotech-etf-on-cancer-treatment-2015-10-19", "https://www.nasdaq.com/articles/ill-at-ease-with-biotech-prescribing-1-healthcare-etfs-2015-09-28", "https://www.nasdaq.com/articles/how-grow-business-2015-09-01", "https://www.nasdaq.com/articles/biotech-boom-over-3-health-care-etfs-to-invest-in-instead-2015-08-13", "https://www.nasdaq.com/articles/small-business-value-improvement-2015-12-30", "https://www.nasdaq.com/articles/your-biotech-etf-keeping-3-new-standouts-2015-07-16", "https://www.nasdaq.com/articles/best-and-worst-etf-performers-march-etf-news-and-commentary-2015-04-01", "https://www.nasdaq.com/articles/healthcare-etfs-rally-monday-merger-mania-etf-news-and-commentary-2015-03-31", "https://www.nasdaq.com/articles/best-and-worst-etfs-week-amid-slowing-corporate-profits-2015-03-28", "https://www.nasdaq.com/articles/sell-biotech-semiconductor-etfs-nice-entry-point-etf-news-and-commentary-2015-03-26", "https://www.nasdaq.com/articles/3-biotech-etfs-in-focus-as-biogen-soars-etf-news-and-commentary-2015-03-23", "https://www.nasdaq.com/articles/new-biotech-etfs-highlight-evolving-growth-opportunities-2015-03-17", "https://www.nasdaq.com/articles/manager-hot-new-biotech-etfs-explains-strategy-2015-07-16", "https://www.nasdaq.com/articles/sbio-vs.-bbc%3A-2-innovative-biotech-etfs-head-to-head-etf-news-and-commentary-2015-03-04", "https://www.nasdaq.com/articles/cut-biz-tax-life-policies-2015-01-23", "https://www.nasdaq.com/articles/alps-puts-twist-on-biotech-investing-with-medical-breakthrough-etf-etf-news-and-commentary", "https://www.nasdaq.com/articles/viral-investing-ebola-drug-makers-varied-strategies-2014-12-26", "https://www.nasdaq.com/articles/inside-the-two-new-innovative-biotech-etfs-from-bioshares-etf-news-and-commentary-2014-12", "https://www.nasdaq.com/articles/2-new-biotech-etfs-offer-unique-industry-focus-2014-12-18", "https://www.nasdaq.com/articles/goldcore-update-gold-marginally-lower-equities-fall-sharply-disappointing-us-job-numbers", "https://www.nasdaq.com/articles/zacks-investment-ideas-feature-highlights%3A-biogen-amgen-spdr-sp-biotech-etf-bioshares"], "Content": []}